
Bruck Kifle
Examiner (ID: 2332)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 1624, 1611, 1622 |
| Total Applications | 3434 |
| Issued Applications | 2601 |
| Pending Applications | 222 |
| Abandoned Applications | 651 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 968604
[patent_doc_number] => 06939878
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-06
[patent_title] => 'Deuterated rapamycin compounds, method and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/754488
[patent_app_country] => US
[patent_app_date] => 2004-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 3580
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/939/06939878.pdf
[firstpage_image] =>[orig_patent_app_number] => 10754488
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/754488 | Deuterated rapamycin compounds, method and uses thereof | Jan 8, 2004 | Issued |
Array
(
[id] => 715980
[patent_doc_number] => 07053081
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-30
[patent_title] => 'Cyclic malonamides as inhibitors of A-β protein production'
[patent_app_type] => utility
[patent_app_number] => 10/746769
[patent_app_country] => US
[patent_app_date] => 2003-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42502
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/053/07053081.pdf
[firstpage_image] =>[orig_patent_app_number] => 10746769
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/746769 | Cyclic malonamides as inhibitors of A-β protein production | Dec 23, 2003 | Issued |
Array
(
[id] => 1034552
[patent_doc_number] => 06875762
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-05
[patent_title] => 'Tetracyclic azepinoindole compounds'
[patent_app_type] => utility
[patent_app_number] => 10/744999
[patent_app_country] => US
[patent_app_date] => 2003-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22219
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/875/06875762.pdf
[firstpage_image] =>[orig_patent_app_number] => 10744999
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/744999 | Tetracyclic azepinoindole compounds | Dec 22, 2003 | Issued |
Array
(
[id] => 7310620
[patent_doc_number] => 20040142950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Amide and ester matrix metalloproteinase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/739261
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32087
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142950.pdf
[firstpage_image] =>[orig_patent_app_number] => 10739261
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/739261 | Amide and ester matrix metalloproteinase inhibitors | Dec 17, 2003 | Abandoned |
Array
(
[id] => 497437
[patent_doc_number] => 07208487
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-24
[patent_title] => 'Compounds, compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 10/538228
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18388
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/208/07208487.pdf
[firstpage_image] =>[orig_patent_app_number] => 10538228
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/538228 | Compounds, compositions and methods | Dec 11, 2003 | Issued |
Array
(
[id] => 606482
[patent_doc_number] => 07153847
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-26
[patent_title] => 'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds'
[patent_app_type] => utility
[patent_app_number] => 10/733877
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 206112
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/153/07153847.pdf
[firstpage_image] =>[orig_patent_app_number] => 10733877
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/733877 | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds | Dec 11, 2003 | Issued |
Array
(
[id] => 7191274
[patent_doc_number] => 20040204500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Preventives/remedies for organ functional disorders and organ dysfunction'
[patent_app_type] => new
[patent_app_number] => 10/480707
[patent_app_country] => US
[patent_app_date] => 2003-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30319
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204500.pdf
[firstpage_image] =>[orig_patent_app_number] => 10480707
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/480707 | Preventives/remedies for organ functional disorders and organ dysfunction | Dec 10, 2003 | Abandoned |
Array
(
[id] => 7337052
[patent_doc_number] => 20040132718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/730170
[patent_app_country] => US
[patent_app_date] => 2003-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41870
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132718.pdf
[firstpage_image] =>[orig_patent_app_number] => 10730170
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/730170 | Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors | Dec 7, 2003 | Issued |
Array
(
[id] => 6906203
[patent_doc_number] => 20050101598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations'
[patent_app_type] => utility
[patent_app_number] => 10/728090
[patent_app_country] => US
[patent_app_date] => 2003-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4987
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101598.pdf
[firstpage_image] =>[orig_patent_app_number] => 10728090
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/728090 | Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations | Dec 4, 2003 | Issued |
Array
(
[id] => 5107711
[patent_doc_number] => 20070066589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Method of preparing 10th-dibenzo[b,f][11,4]thiazepin-11-one'
[patent_app_type] => utility
[patent_app_number] => 10/533052
[patent_app_country] => US
[patent_app_date] => 2003-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2340
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20070066589.pdf
[firstpage_image] =>[orig_patent_app_number] => 10533052
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/533052 | Method of preparing 10H-dibenzo[b,f][11,4]thiazepin-11-one | Nov 25, 2003 | Issued |
Array
(
[id] => 7411338
[patent_doc_number] => 20040106593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-03
[patent_title] => 'Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same'
[patent_app_type] => new
[patent_app_number] => 10/721714
[patent_app_country] => US
[patent_app_date] => 2003-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8160
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20040106593.pdf
[firstpage_image] =>[orig_patent_app_number] => 10721714
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/721714 | Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same | Nov 24, 2003 | Issued |
Array
(
[id] => 7615201
[patent_doc_number] => 06897323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-24
[patent_title] => 'Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same'
[patent_app_type] => utility
[patent_app_number] => 10/722283
[patent_app_country] => US
[patent_app_date] => 2003-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8146
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/897/06897323.pdf
[firstpage_image] =>[orig_patent_app_number] => 10722283
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/722283 | Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same | Nov 24, 2003 | Issued |
Array
(
[id] => 7291553
[patent_doc_number] => 20040110824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => '2-Phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents'
[patent_app_type] => new
[patent_app_number] => 10/720504
[patent_app_country] => US
[patent_app_date] => 2003-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33696
[patent_no_of_claims] => 107
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110824.pdf
[firstpage_image] =>[orig_patent_app_number] => 10720504
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/720504 | 2-phenyl-1-4(2-aminoethoxy)-benzyl-indoles as estrogenic agents | Nov 23, 2003 | Issued |
Array
(
[id] => 820618
[patent_doc_number] => 07407951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-05
[patent_title] => 'Pyrrolobenzodiazepines'
[patent_app_type] => utility
[patent_app_number] => 10/534825
[patent_app_country] => US
[patent_app_date] => 2003-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20174
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/407/07407951.pdf
[firstpage_image] =>[orig_patent_app_number] => 10534825
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/534825 | Pyrrolobenzodiazepines | Nov 13, 2003 | Issued |
Array
(
[id] => 483291
[patent_doc_number] => 07220755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-22
[patent_title] => '42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same'
[patent_app_type] => utility
[patent_app_number] => 10/706055
[patent_app_country] => US
[patent_app_date] => 2003-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 35
[patent_no_of_words] => 13408
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/220/07220755.pdf
[firstpage_image] =>[orig_patent_app_number] => 10706055
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/706055 | 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same | Nov 11, 2003 | Issued |
Array
(
[id] => 5591670
[patent_doc_number] => 20060041122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Method for purifying caprolactam'
[patent_app_type] => utility
[patent_app_number] => 10/534802
[patent_app_country] => US
[patent_app_date] => 2003-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5307
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20060041122.pdf
[firstpage_image] =>[orig_patent_app_number] => 10534802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/534802 | Purification of caprolactam | Nov 10, 2003 | Issued |
Array
(
[id] => 7276671
[patent_doc_number] => 20040236122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Transformation of tricyclopentabenzene (trindane) to 12 - hydroxy - 16 - oxatetracyclo [10.3.1.01.5 .07.11] hexadec - 7(11) - en -2,6- dione'
[patent_app_type] => new
[patent_app_number] => 10/702233
[patent_app_country] => US
[patent_app_date] => 2003-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1323
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20040236122.pdf
[firstpage_image] =>[orig_patent_app_number] => 10702233
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/702233 | Transformation of tricyclopentabenzene (trindane) to 12 - hydroxy - 16 - oxatetracyclo [10.3.1.01.5 .07.11] hexadec - 7(11) - en -2,6- dione | Nov 5, 2003 | Abandoned |
Array
(
[id] => 6918763
[patent_doc_number] => 20050096324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Macrocyclic kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/702140
[patent_app_country] => US
[patent_app_date] => 2003-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9313
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20050096324.pdf
[firstpage_image] =>[orig_patent_app_number] => 10702140
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/702140 | Macrocyclic kinase inhibitors | Nov 4, 2003 | Abandoned |
Array
(
[id] => 4652227
[patent_doc_number] => 20080039483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Novel Chelidonine Derivatives, Methods for the Production Thereof, and Use Thereof For Producing Pharmaceutical Agents'
[patent_app_type] => utility
[patent_app_number] => 10/595699
[patent_app_country] => US
[patent_app_date] => 2003-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7998
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039483.pdf
[firstpage_image] =>[orig_patent_app_number] => 10595699
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/595699 | Novel Chelidonine Derivatives, Methods for the Production Thereof, and Use Thereof For Producing Pharmaceutical Agents | Nov 4, 2003 | Abandoned |
Array
(
[id] => 5913633
[patent_doc_number] => 20060128695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses'
[patent_app_type] => utility
[patent_app_number] => 10/533157
[patent_app_country] => US
[patent_app_date] => 2003-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 32876
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20060128695.pdf
[firstpage_image] =>[orig_patent_app_number] => 10533157
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/533157 | Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses | Oct 29, 2003 | Abandoned |